The Expression of Inflammatory Mediators in Bladder Pain Syndrome

[1]  A. Ackerman,et al.  Chronic psychological stress in high-anxiety rats induces sustained bladder hyperalgesia , 2015, Physiology & Behavior.

[2]  G. Anderson,et al.  CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice , 2015, European journal of immunology.

[3]  S. Walker,et al.  Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome. , 2014, The Journal of urology.

[4]  L. Birder,et al.  Evidence for Bladder Urothelial Pathophysiology in Functional Bladder Disorders , 2014, BioMed research international.

[5]  Rafael J. Yáñez-Muñoz,et al.  Large-Scale Chondroitin Sulfate Proteoglycan Digestion with Chondroitinase Gene Therapy Leads to Reduced Pathology and Modulates Macrophage Phenotype following Spinal Cord Contusion Injury , 2014, The Journal of Neuroscience.

[6]  M. Fall,et al.  Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis , 2014, International journal of urology : official journal of the Japanese Urological Association.

[7]  T. L. Thuoc,et al.  An overview on keratinocyte growth factor: from the molecular properties to clinical applications. , 2014, Protein and peptide letters.

[8]  Yuan-Hong Jiang,et al.  Increased Pro-Inflammatory Cytokines, C-Reactive Protein and Nerve Growth Factor Expressions in Serum of Patients with Interstitial Cystitis/Bladder Pain Syndrome , 2013, PloS one.

[9]  V. Viereck,et al.  Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C , 2013, International Urogynecology Journal.

[10]  H. Kuo,et al.  Increased Urine and Serum Nerve Growth Factor Levels in Interstitial Cystitis Suggest Chronic Inflammation Is Involved in the Pathogenesis of Disease , 2012, PloS one.

[11]  Matthias Kohl,et al.  ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data , 2012, BMC Genomics.

[12]  Christophe Ladroue,et al.  Comparative Lipidomics Profiling of Human Atherosclerotic Plaques , 2011, Circulation. Cardiovascular genetics.

[13]  H. Boddeke,et al.  Neuronal CCL21 up‐regulates microglia P2X4 expression and initiates neuropathic pain development , 2011, The EMBO journal.

[14]  M. Volin,et al.  Characterization of CCL19 and CCL21 in rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[15]  S. McColl,et al.  The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. , 2010, Blood.

[16]  S. McMahon,et al.  Chondroitinase ABC-Mediated Plasticity of Spinal Sensory Function , 2008, The Journal of Neuroscience.

[17]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[18]  F. Martinez,et al.  Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. , 2007, The American journal of pathology.

[19]  C. Parsons,et al.  The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. , 2007, Urology.

[20]  S. Clarke,et al.  Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Milani,et al.  The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. , 2003, Gastroenterology.

[22]  C. Serdar,et al.  Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Magnus Fall,et al.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. , 2003, Urology.

[24]  A. Ford,et al.  A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction , 2001, BJU international.

[25]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[26]  J. Koziol.  Epidemiology of interstitial cystitis. , 1994, The Urologic clinics of North America.

[27]  M. Fall,et al.  Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis. , 1990, The Journal of urology.

[28]  S. McMahon,et al.  A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals , 1987, Pain.

[29]  M. Fall,et al.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. , 2008, European urology.